Jefferies Financial Group Issues Pessimistic Forecast for Sarepta Therapeutics (NASDAQ:SRPT) Stock Price
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target cut by investment analysts at Jefferies Financial Group from $125.00 to $54.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. Jefferies Financial Group’s price objective would suggest a potential upside of 150.46% […]
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target cut by investment analysts at Jefferies Financial Group from $125.00 to $54.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. Jefferies Financial Group’s price objective would suggest a potential upside of 150.46% […]
